The share price of biopharmaceutical company Immunome Inc (NASDAQ: IMNM) has skyrocketed on Thursday after the company said its discovery engine has isolated potent antibodies capable of neutralizing several coronavirus variants, including the South African variant.
The effort is part of Immunome’s ongoing programme to develop a cocktail of antibodies targeting spike and non-spike proteins to serve as a treatment for COVID-19.
The Nasdaq listed company said that through its research, it found that Covid-19 “super-responders” who recover from Covid-19 mount a robust immune response to a broad range of viral targets, including spike and non-spike proteins.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“Immunome’s research shows that certain of our antibodies neutralize pseudoviruses expressing the spike protein of the South African Variant,” Immunome stated.
The company’s CEO, Purnanand Sarma, said they believe their “comprehensive strategy could combat the negative impact of escape mutants. We are encouraged by these results and plan to continue development efforts on these antibodies.”
The company’s shares rose over 200% premarket. Shortly after the open on Wall Street, they are trading up 106% on the day at $45.91.
